Artificial intelligence-based measurements of PET/CT imaging biomarkers are associated with disease-specific survival of high-risk prostate cancer patients

CONCLUSION: AI-based assessments of total tumour volume and lesion uptake were significantly associated with disease-specific survival in this patient cohort, whereas SUVmax and Gleason scores were not. The AI-based approach appears well-suited for clinically relevant patient stratification and monitoring of individual therapy.PMID:34565290 | DOI:10.1080/21681805.2021.1977845

Source: Scandinavian Journal of Urology - September 27, 2021 Category: Urology & Nephrology Authors: Eirini Polymeri Henrik Kj ölhede Olof Enqvist Johannes Ul én Mads H Poulsen Jane A Simonsen Pablo Borrelli Elin Tr ägårdh Åse A Johnsson Poul Flemming H øilund-Carlsen Lars Edenbrandt Source Type: research